2024 Critical Care Congress Skip to main content
2024 Critical Care Congress Main banner
Back

Sepsis

Category: One-Hour Concurrent Session

Rethinking Vasopressors: Evolving Evidence and Emerging Concepts in Vasopressor Administration

(1456654-02) Sooner or Later: When Should We Start to Add Vasopressors?

Sunday, January 21, 2024
10:50 AM – 11:05 AM MT
Location: North-120BCD
Disclosure(s):
Ithan Peltan, MD,: Janssen Pharmaceuticals: Contracted Research (Terminated); Regeneron: Contracted Research (Terminated)

This session will review timing of vasopressor initiation, covering two key areas: 1) the role of early vasopressor initiation and what we can learn from the recent CLOVERS trial, and 2) when to add Vasopressin in patients already on Norepinephrine, highlighting existing practice variation and the role policy and cost play in decisions about Vasopressin use.